Govt to amend Drugs Rules to crack down on Fake Documents

The Drugs Technical Advisory Board (DTAB) has proposed a significant amendment to the Drugs Rules.

234
Act Rule Law
Picture: Pixabay

Last Updated on October 22, 2024 by The Health Master

Drugs Rules

Drugs Rules: The drug regulatory authority in India is set to tighten its grip on applicants who submit misleading or fabricated documents for regulatory approvals.

This move aims to ensure the integrity of the drug approval process and protect public health.

Current Lack of Provisions

Until now, the Drugs Rules, 1945, have not explicitly addressed the issue of applicants providing forged or misleading data.

This has created a loophole that has been exploited by some unscrupulous entities.

DTAB’s Recommendation

The Drugs Technical Advisory Board (DTAB) has proposed a significant amendment to the Drugs Rules.

This amendment would allow for stricter penalties against applicants who submit fraudulent documents.

The DTAB recommends debarring such applicants from future submissions and possibly suspending or canceling their product approvals.

Previous Actions by Drug Regulatory Authority

While there hasn’t been a specific provision in place, the drug regulatory authority has been taking action against applicants who submit fake documents.

In one notable case in 2015, the FDC division of the DCGI office rejected an application and debarred the applicant for five years due to forged data.

Instances of Fraudulent Submissions

There have been multiple instances where companies have been accused of submitting fraudulent documents to the drug regulatory authority.

This has raised concerns about the integrity of the drug approval process and the safety of drugs available in the market.

Previous Efforts to Tighten Regulations

The Union health ministry has previously attempted to strengthen the provisions under Schedule Y of the Drugs Rules to address the issue of fraudulent documents.

These efforts aimed to ensure the authenticity of the data submitted by applicants.

In conclusion, The proposed amendment to the Drugs Rules is a crucial step towards ensuring the integrity of the drug approval process.

By imposing stricter penalties on applicants who submit fake documents, the drug regulatory authority can protect public health and maintain the credibility of the Indian drug market.

Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news